1. Phase II study of cetuximab with irinotecan for KRAS wild‐type colorectal cancer in Japanese patients. Issue 2 (6th August 2015) Authors: Terazawa, Tetsuji; Nishitani, Hitoshi; Kato, Ken; Hashimoto, Hironobu; Akiyoshi, Kohei; Ito, Yuriko; Nakamoto, Akihiro; Iwasa, Satoru; Nakajima, Takako Eguchi; Hamaguchi, Tetsuya; Yamada, Yasuhide; Shimada, Yasuhiro Journal: Asia-Pacific journal of clinical oncology Issue: Volume 13:Issue 2(2017) Page Start: e132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE. Issue 2 (10th January 2022) Authors: Hata, Akito; Okamoto, Isamu; Inui, Naoki; Okada, Morihito; Morise, Masahiro; Akiyoshi, Kohei; Takeda, Masayuki; Watanabe, Yasutaka; Sugawara, Shunichi; Shinagawa, Naofumi; Kubota, Kaoru; Saeki, Toshiaki; Tamura, Tomohide Journal: Journal of clinical oncology Issue: Volume 40:Issue 2(2022) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗